Xcout Intel
Cognition Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Cognition Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Cognition Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Cognition Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. is a public, clinical-stage biopharmaceutical company founded in 2007 and headquartered in Purchase, New York. The company develops therapies designed to protect neurons and advance treatments for patients living with age-related neurodegenerative diseases.
Cognition Therapeutics, Inc. at a glance
Cognition Therapeutics, Inc. is a biotechnology company headquartered in Purchase, United States, founded in 2007. It is publicly listed (CGTX) with a market capitalisation of $91.3M. Xcout tracks 14 named people at Cognition Therapeutics, Inc., including Lisa Ricciardi (Chief Executive Officer, President & Director).
Cognition Therapeutics, Inc. leadership
- Lisa RicciardiChief Executive Officer, President & Director
- John Brendan DoyleChief Financial Officer
- Anthony O. CaggianoChief Medical Officer
- Steven A. WeissmanVice President & Head of CMC
- Anita CornetHead of Quality
- Bobby HornCorporate Controller
8 more named people on record for Cognition Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Top 12 Cognition Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Cognition Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Life Sciences
Cortexyme, Inc. is a biopharmaceutical company headquartered in South San Francisco, California, focused on discovering and developing therapeutics for major degenerative disorders.
Similar biotechnology company
Alzheon, Inc. is a clinical-stage biopharmaceutical company headquartered in Framingham, Massachusetts. Founded in 2013, the company is dedicated to developing a broad portfolio of investigational therapeutic products for neurodegenerative disorders, including Alzheimer's disease. Its research centers on advancing disease-modifying treatments for patients with cognitive decline.
Similar biotechnology company
Recognify Life Sciences is a clinical-stage biotechnology company located in California, focusing on developing treatments for cognitive impairment associated with central nervous system disorders.
Similar biotechnology company
CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies to treat neurodegenerative diseases by targeting specific receptor systems in the brain. The company's scientific approach focuses on restoring neurovascular and neuronal function to serve patients suffering from conditions such as Parkinson's disease and other neurodegenerative disorders.
Similar biotechnology company
Jocasta Neuroscience, Inc. is a preclinical-stage biotechnology company located in Scottsdale, Arizona and San Francisco, California. The company specializes in developing longevity-focused therapies for cognitive impairment.
Similar biotechnology company
Muna Therapeutics is a privately held biopharmaceutical company founded in 2020 with headquarters in Copenhagen, Denmark, and operations in Leuven. The company discovers and develops novel therapies aimed at slowing or stopping devastating neurodegenerative diseases like Alzheimer's and Parkinson's.
Similar biotechnology company
Avraham Pharmaceuticals Ltd. is a biotechnology company headquartered in Yavneh, Israel, founded in 2010. The company develops novel small molecule drugs and multi-functional drug substances, such as ladostigil, aimed at the treatment and prevention of neurodegenerative disorders and mild cognitive impairment.
Similar biotechnology company
ProJenX, Inc. is a clinical-stage biotechnology company founded in 2021 and headquartered in New York City. The firm focuses on neuroscience, developing novel, brain-penetrant therapies targeting biologically defined motor neuron diseases such as ALS. It advances research programs aimed at addressing severe neurodegenerative conditions.
Similar biotechnology company
AriBio is a clinical-stage biopharmaceutical company founded in 2010 and headquartered in Seongnam, South Korea, with additional offices in the United States. The company focuses on developing novel therapeutics for neurodegenerative diseases.
Life Sciences
Cajal Neuroscience (Cajal Therapeutics Inc.) is a biotechnology company headquartered in Seattle, Washington. The company is dedicated to advancing therapeutic pipelines in neuroscience research.
Biotech
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Similar biotechnology company
Myrobalan Therapeutics is a pre-clinical biotechnology company headquartered in Medford, Massachusetts, focused on developing oral small molecule therapies for central nervous system and neurodegenerative diseases. The company targets novel mechanisms to create neurorestorative treatments for CNS disorders.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Cognition Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Cognition Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →